VE303, A LIVE BIOTHERAPEUTIC PRODUCT FOR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE (C. DIFFICILE) INFECTION. PRELIMINARY RESULTS OF A PHASE 1, OPEN-LABEL HEALTHY VOLUNTEERS STUDY OF ORAL VE303 AFTER VANCOMYCIN

Dmitri Bobilev, Lou Vaickus, Paolo DePetrillo,Brian Klein,Shilpa Reddy,Bernat Olle,Bruce Roberts,Jason Norman

Gastroenterology(2019)

引用 5|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要